Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

PC Connection Shares Plummet to Annual Low Following Earnings Disappointment

Robert Sasse by Robert Sasse
November 1, 2025
in Analysis, Earnings, Tech & Software
0
PC Connection Stock
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

PC Connection finds itself navigating turbulent market conditions. The technology solutions provider witnessed its stock value collapse to a fresh 52-week low in the wake of a disappointing quarterly earnings report, signaling investor disapproval of the company’s stalled growth momentum.

Market Reaction to Q3 Performance

The financial markets delivered a swift verdict. PC Connection shares tumbled to a new annual low of $55.50 before settling at a closing price of $56.63. This downturn extends a challenging period for the equity, which has declined 11.34% since the start of the year and shows a negative 5.24% return over the past twelve months, reinforcing a persistent downward trajectory.

The third quarter of 2025 proved particularly difficult. The company reported earnings of $0.97 per share, falling short of the $1.01 per share that analysts had projected. Revenue performance was even more concerning, contracting by 2.2% year-over-year to $709.07 million and missing revenue forecasts by 4.66%. A review of recent history reveals the company has surpassed revenue expectations only once in the past four quarters, raising significant questions about its sales vitality.

Key Financial Metrics:
* Q3 EPS: $0.97 (Missed Expectations)
* Q3 Revenue: $709.07 Million (Down 2.2% Year-Over-Year)
* Gross Margin: 19.6% (Increased 0.9 Percentage Points)
* Quarterly Dividend: $0.15 Per Share

Should investors sell immediately? Or is it worth buying PC Connection?

A Glimmer of Operational Efficiency

Despite the top-line weakness, a notable bright spot emerged in the company’s profitability. PC Connection achieved a record gross profit of $138.6 million, an increase of 2.4%. This was attributed to a strategic shift toward higher-margin business segments, including cloud software, cybersecurity, and service offerings. The improved gross margin of 19.6% suggests that while overall sales are shrinking, the company is becoming more efficient in the sales it does make.

Shareholder Returns Amid the Slump

In a move to potentially reassure investors, the company’s board has maintained its commitment to returning capital to shareholders. A quarterly cash dividend of $0.15 per share was declared, payable on November 28. At the current share price, this distribution yields approximately 1.0%. The company has also been active in buying back its own stock, repurchasing over one million shares at an average price of $63.17 each. Furthermore, PC Connection maintains a solid balance sheet with more cash than debt, providing a fundamental cushion.

Divided Analyst Sentiment

The conflicting signals—declining revenue but rising gross profit—have created a split among market experts. The analyst community is currently divided; some perceive the stock as undervalued and suggest a fair value target of $76, while others have already downgraded their assessments. The central uncertainty remains: Do the aggressive buybacks and strong operational margins signal an impending sustainable recovery for PC Connection, or does the recent earnings miss and revenue contraction mark the beginning of a more prolonged decline?

Ad

PC Connection Stock: Buy or Sell?! New PC Connection Analysis from February 7 delivers the answer:

The latest PC Connection figures speak for themselves: Urgent action needed for PC Connection investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

PC Connection: Buy or sell? Read more here...

Tags: PC Connection
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Graftech Stock
Commodities

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Next Post
Kilroy Realty Stock

Kilroy Realty's Stellar Quarter Fuels Market Rally

Global Medical Reit Stock

Healthcare REIT Faces Critical Earnings Test with Major Upside Potential

Unum Stock

Unum Shares Face Pressure Ahead of Quarterly Earnings Release

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com